“This is a big day. Twenty-six years ago my father made me a promise that there would be a cure for paralysis. Today we are taking a huge step to make it happen.”
— Marc Buoniconti, president of The Miami Project

Marc Buoniconti demonstrates the Lokomat locomotor training machine.

Marc Buoniconti demonstrates the Lokomat locomotor training machine.

On July 31, 2012, Marc Buoniconti and other principals of The Miami Project to Cure Paralysis, The
Buoniconti Fund and the University of Miami, gathered at The Miami Project to trumpet the news: The FDA had given the Project the go-ahead to conduct a phase I human Schwann cell clinical trial. Slightly less than six months later, the first Schwann cell transplantation took place at the University of Miami/Jackson Memorial Medical Center.

The trial, which Neurology Today called “a landmark study,” is the only approved cell therapy trial for spinal cord injury in the United States and the first for Schwann